Biocon shares rise 2% on deal with Sandoz
Biocon Biologics, a subsidiary of Biocon, has signed a distribution agreement with Sandoz for an immunity-linked injection in Japan.
biocon shares
December 2023
August 2023
May 2023
Biocon shares down 5% on 30% dip in Q1 profit
Biocon Ltd reported a decline in the net profit in the April to June quarter by 30% to ₹101.4 crore as against ₹144.40 crore in the same period last year.
Biocon shares jump 7% on strong Q4, dividend declaration
Biocon declared a dividend of ₹1.50 per share for FY23, which includes payout on account of one-time exceptional gains arising from partial monetisation of its holdings in Syngene
